IL37 and Cowden disease: Fluoroquinolone and trimethoprim-sulfamethoxazole are first-line agents. Ustekinumab is a monoclonal antibody to the p40 subunit of interleukin-12 and interleukin-23 used in a patient with moderate to severely active CD.